Rubric Capital Management (New York)’s Mereo BioPharma MREO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.05M	Hold	15,307,347	–	–	0.06%	77
2025 Q4	$6.38M	Hold	15,307,347	–	–	0.08%	71
2025 Q3	$31.5M	Hold	15,307,347	–	–	0.42%	47
2025 Q2	$41.5M	Hold	15,307,347	–	–	0.67%	39
2025 Q1	$34.4M	Hold	15,307,347	–	–	0.62%	37
2024 Q4	$53.6M	Hold	15,307,347	–	–	0.97%	30
2024 Q3	$62.9M	Hold	15,307,347	–	–	1.03%	25
2024 Q2	$55.1M	Buy	15,307,347 +1,754,350	+13%	+$5.68M	1.45%	28
2024 Q1	$44.7M	Hold	13,552,997	–	–	1.32%	27
2023 Q4	$31.3M	Buy	13,552,997 +1,936,877	+17%	+$3.7M	1.17%	33
2023 Q3	$15M	Hold	11,616,120	–	–	0.63%	41
2023 Q2	$15.3M	Buy	11,616,120 +1,250,000	+12%	+$1.45M	0.66%	40
2023 Q1	$7.33M	Hold	10,366,120	–	–	0.29%	59
2022 Q4	$7.77M	Hold	10,366,120	–	–	0.34%	62
2022 Q3	$8.93M	Sell	10,366,120 -6,390,000	-38%	-$7.82M	0.45%	48
2022 Q2	$18.8M	Buy	16,756,120 +1,756,120	+12%	+$1.36M	0.99%	32
2022 Q1	$16.8M	Buy	15,000,000 +85,553	+0.6%	+$111K	0.78%	40
2021 Q4	$23.9M	Buy	14,914,447 +3,614,447	+32%	+$7.23M	1.13%	31
2021 Q3	$27.3M	Buy	11,300,000 +5,639,392	+100%	+$14.9M	1.57%	30
2021 Q2	$17.9M	Buy	5,660,608 +2,745,747	+94%	+$9.21M	1.13%	37
2021 Q1	$9.82M	Buy	2,914,861 +1,061,444	+57%	+$3.75M	0.58%	47
2020 Q4	$6.63M	Buy	+1,853,417	New	+$4.64M	0.51%	48

Other funds holding MREO